|
Real-time Estimate
Cboe BZX
18:42:31 01/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 2.875 USD | -14.18% |
|
-17.13% | -79.84% |
| 09-21 | Seres Therapeutics, Inc.(NasdaqGS:MCRB) dropped from S&P Global BMI Index | CI |
| 08-14 | Seres Therapeutics Files $300 Million Mixed Shelf | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 33.3M | - | - | - | ||
| 74.46B | |||||
| 60.14B | |||||
| 48.15B | |||||
| 44.25B | |||||
| 43.99B | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
